Max Healthcare Institute Ltd
Diversified Consumer Services | Large Cap
Max Healthcare Institute Ltd demonstrates a mixed financial performance. The company shows strong solvency, reflecting a sound capital structure. Growth in revenue and operating profit is robust, indicating market expansion and efficient operations. Profitability metrics, such as gross profit margin, return on assets, and operating margin, are also strong. However, liquidity ratios are low, suggesting potential challenges in meeting short-term obligations. Additionally, some financial metrics such as Adjusted EPS and Book Value Per Share, and profitability ratios such as Return on Equity and Net Margin are low. While the company exhibits good interest coverage, its dividend coverage is weak. Overall, Max Healthcare shows potential for growth and profitability, but it should focus on improving its short-term financial health and some financial metrics to ensure long-term sustainability.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllMax Healthcare among 3 largecap stocks flashing bullish signals, hinting at a possible uptrend
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio6.00
- Financial Ratio4.40
- Profitability Ratio7.20
- Efficiency Ratio4.67
- Coverage Ratio6.80
- Solvency Ratio10.00
- Liquidity Ratio2.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBullish
- 2 HoursBullish
- 4 HoursBullish
- 1 DayBullish
- 1 WeekNeutral
- 1 MonthBearish
Max Healthcare Institute Ltd demonstrates a mixed financial performance. The company shows strong solvency, reflecting a sound capital structure. Growth in revenue and operating profit is robust, indicating market expansion and efficient operations. Profitability metrics, such as gross profit margin, return on assets, and operating margin, are also strong. However, liquidity ratios are low, suggesting potential challenges in meeting short-term obligations. Additionally, some financial metrics such as Adjusted EPS and Book Value Per Share, and profitability ratios such as Return on Equity and Net Margin are low. While the company exhibits good interest coverage, its dividend coverage is weak. Overall, Max Healthcare shows potential for growth and profitability, but it should focus on improving its short-term financial health and some financial metrics to ensure long-term sustainability.
Overall Valuation Score
P/E RATIO (TTM)
148.16
Industry Median
47.85
Large Cap Median
67.93
P/E RATIO
73.58
P/B RATIO
9.91
Industry Median
4.57
Large Cap Median
11.34
P/S RATIO
12.58
Industry Median
3.59
Large Cap Median
8.67
Others
PEG RATIO
0.00
EV/EBITDA RATIO
45.64
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹1090.45 as on Jun 18, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The growth of Max Healthcare shows a mixed performance. Revenue and Operating Profit growth rates are high, indicating strong market expansion and operational efficiency. However, EPS and Net Income Growth rates are low. Asset Growth Rate is also high, suggesting significant investments in assets. Overall, the company is growing in terms of revenue and assets, but needs to improve its net income and EPS.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 56.98 | 15.9 | 18.47 | 30 | 19.14 |
| Operating Profit Growth Rate | 133.66 | 30.49 | 20.31 | 23.84 | 21.31 |
| Earnings Per Share (EPS) Growth | -539.44 | 82.21 | -4.31 | 1.75 | 33.88 |
| Asset Growth Rate | 7.56 | 9.94 | 18.79 | 26.55 | 13.47 |
| Net Income Growth Rate | -538.41 | 82.48 | -4.17 | 1.7 | 34.01 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The financial metrics of Max Healthcare presents a varied picture. Capital Expenditures is good. Cash EPS and DPS are weak, while Adjusted EPS and Book Value Per Share is also low. Overall, the company needs to improve its financial metrics related to earnings and shareholder value.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 6.34 | 11.36 | 10.88 | 11.65 | 15.25 |
| Cash Earnings Per Share (Cash EPS) | 8.52 | 13.76 | 13.41 | 14.76 | 19.41 |
| Book Value Per Share | 64.77 | 76.31 | 86.5 | 96.51 | 110.45 |
| Dividend Per Share (DPS) | 0 | 1.02 | 1.52 | 1.55 | 1.93 |
| Capital Expenditures (CapEx) | 548 | 332 | 780 | 960 | 1469 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The profitability of Max Healthcare is a mixed bag. Gross Profit Margin, Return on Assets, and Operating Margin are strong. But Return on Equity and Net Margin are low. Overall, while the company is profitable at the operating level, it needs to improve its overall profitability and returns to equity holders.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 18.54 | 22.11 | 23.09 | 21.2 | 21.45 |
| Return on Capital Employed (ROCE) | 12 | 15 | 16 | 15 | 15 |
| Return on Equity (ROE) | 9.63 | 14.9 | 12.58 | 11.47 | 13.42 |
| Return on Assets (ROA) | 10.35 | 12.28 | 12.44 | 12.18 | 13.02 |
| Operating Margin | 24.16 | 27.2 | 27.62 | 26.31 | 26.79 |
| Net Margin | 15.37 | 24.19 | 19.57 | 15.31 | 17.22 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The efficiency of Max Healthcare depicts a mixed scenario. The Days Sales in Inventory Ratio and Receivable Days are good. But other efficiency metrics like Fixed Asset Turnover Ratio, Inventory Turnover Ratio, Receivables Turnover Ratio, and Capital Turnover Ratio are low. This indicates the company is not generating enough revenue from its assets. The company should focus on using its assets more efficiently to increase revenue.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 0.56 | 0.65 | 0.62 | 0.61 | 0.64 |
| Inventory Turnover Ratio | 55.77 | 51.88 | 53.31 | 59.56 | 59.8 |
| Receivables Turnover Ratio | 10.48 | 12.66 | 13.53 | 12.22 | 10.11 |
| Days Sales in Inventory Ratio | 6.54 | 7.04 | 6.85 | 6.13 | 6.1 |
| Receivable Days | 34.83 | 28.83 | 26.98 | 29.87 | 36.1 |
| Capital Turnover Ratio | 0.55 | 0.57 | 0.56 | 0.58 | 0.61 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The Interest Coverage Ratio is high, indicating a strong ability to meet interest obligations. However, the Equity Dividend Coverage Ratio is low. This suggests the company may have difficulty in covering dividend payments with its equity. Overall, the company is able to cover its interest expenses but needs to improve its dividend coverage.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 8.32 | 13.67 | 23.75 | 9.52 | 8.13 |
| Equity Dividend Coverage Ratio | 11.11 | 7.14 | 7.14 | 7.69 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company's solvency position is strong, with high equity ratio and low debt ratios. This suggests a solid capital structure and a conservative approach to financial leverage. The company relies more on equity than debt. This indicates financial stability and reduces the risk of financial distress.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.11 | 0.08 | 0.13 | 0.23 | 0.22 |
| Debt to Equity Ratio | 0.12 | 0.09 | 0.15 | 0.3 | 0.28 |
| Equity Ratio | 0.89 | 0.92 | 0.87 | 0.77 | 0.78 |
| Debt To Asset Ratio | 0.09 | 0.06 | 0.1 | 0.18 | 0.17 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's liquidity position appears weak as all the liquidity ratios such as current, quick, cash and operating cash flow are very low. This suggests potential difficulties in meeting short-term obligations. While a low liquidity ratio might indicate efficient cash management, it also raises concerns about the company's ability to handle unexpected financial demands. A cautious approach to managing current assets and liabilities is advisable.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 0.97 | 1.36 | 1.12 | 0.92 | 1.05 |
| Quick Ratio | 0.94 | 1.32 | 1.08 | 0.89 | 1.02 |
| Cash Ratio | 0.24 | 0.71 | 0.46 | 0.23 | 0.2 |
| Operating Cash Flow Ratio | 0.35 | 0.62 | 0.47 | 0.48 | 0.47 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Fortis Healthcare Ltd | 6.50 | 69.47 | Neutral | 2085.00 | 3.05 | 1064.00 |
| 2 | Apollo Hospitals Enterprise Ltd | 6.29 | 62.29 | Neutral | 3769.00 | 103.81 | 2003.00 |
| 3 | Max Healthcare Institute Ltd | 5.61 | 73.58 | Neutral | 2243.00 | 7.36 | 1442.00 |
Max Healthcare's management effectiveness presents a mixed picture. Strong revenue growth, evidenced by compounded sales growth and increasing quarterly sales, indicates operational strengths. High institutional interest reflects market confidence. However, profit growth volatility and a decrease in promoter holding raise concerns. The company's capital efficiency is also mixed, with fluctuating ROCE. These factors suggest a need for management to address profit growth consistency and capital management.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Revenue Growth | 21% 3Y CAGR | Strong sales growth and operational efficiency. |
| Institutional Holding | 54.74% FII | High institutional interest. | |
| CONS | Profit Growth Volatility | 0% Mar 2024 YOY Profit Growth % | Inconsistent profit growth in recent quarters. |
| Promoter Holding Decrease | 23.74% | Significant decrease in promoter holding. |
Financial Performance & Growth
Max Healthcare's financial performance shows strong revenue growth but inconsistent profit growth. The compounded sales growth has been robust, with a 3-year CAGR of 21% and a TTM growth of 30%. Quarterly sales have consistently increased, from ₹937 Cr in Mar 2022 to ₹1,910 Cr in Mar 2025. However, profit growth has been volatile. While the 5-year compounded profit growth is strong at 64%, the 3-year CAGR is 23% and the TTM growth is 7%. Quarterly profit growth shows significant fluctuations, with a 0% YOY growth in Mar 2024. OPM has remained relatively stable, ranging between 22% and 29% over the quarters.
| Metric | 2019 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Sales Growth (%) | -2.20% | 56.96% | 15.90% | 18.49% | 30.01% |
| OPM (%) | 9% | 24% | 27% | 28% | 26% |
Capital Efficiency & Returns
Capital efficiency and returns for Max Healthcare present a mixed picture. ROCE has fluctuated, showing improvement over the years but with recent stabilization. The current ROCE stands at 11.82%. ROE has also shown variability, with a current ROE of 9.41%. The company's cash conversion cycle is negative, indicating efficient working capital management, but this efficiency has varied over the years.
| Metric | Mar 2019 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| ROCE (%) | 6% | 12% | 15% | 16% | 15% |
| Cash Conversion Cycle (Days) | -188 | -114 | -158 | -164 | -138 |
Financial Health & Prudence
Max Healthcare's financial health and prudence indicate some areas of concern. The debt levels have increased significantly, with borrowings rising from ₹689 Cr in Mar 2023 to ₹3,010 Cr in Mar 2025. Dividend payout has increased, with 14% payout in Mar 2024 and Mar 2025.
| Metric | Mar 2019 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Borrowings (Cr) | 1,003 | 913 | 689 | 1,299 | 3,010 |
| Dividend Payout (%) | 0% | 0% | 9% | 14% | 14% |
Shareholding & Ownership Structure
The shareholding pattern of Max Healthcare shows a significant shift in promoter and institutional holdings. Promoter holding has decreased from 70.46% in Mar 2021 to 23.74% in Mar 2025. FII holding has increased significantly from 17.96% in Mar 2021 to 54.74% in Mar 2025. DII holding has also increased from 4.88% in Mar 2021 to 17.59% in Mar 2025.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Promoter Holding (%) | 70.46 | 50.64 | 23.77 | 23.75 | 23.74 |
| FII Holding (%) | 17.96 | 14.59 | 51.96 | 57.33 | 54.74 |
| DII Holding (%) | 4.88 | 17.57 | 19.36 | 14.96 | 17.59 |
The risk assessment for Max Healthcare reveals a moderate risk profile. Segment performance volatility is a concern due to fluctuations in quarterly profit growth. The increase in borrowings affects financial risk. Overall, the risk is assessed as moderate due to financial concerns and the need for monitoring segment performance and debt levels.
Segment performance volatility
Segment performance volatility is evident in Max Healthcare's quarterly results. The YOY Profit Growth % shows significant fluctuations, ranging from a high of 203% in Sep 2022 to a low of -40% in Sep 2023, and then recovering to 27% in Mar 2025.
Foreign exchange or interest rate exposure
Max Healthcare's exposure to interest rate fluctuations is evident from the increasing interest payments. Quarterly interest expenses have risen from ₹22 Cr in Mar 2022 to ₹55 Cr in Mar 2025. Annual interest expenses have also increased from ₹84 Cr in Mar 2023 to ₹165 Cr in Mar 2025.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 101090.27Bullish
- SMA 201068.37Bullish
- SMA 501038.70Bullish
- EMA 101086.76Bullish
- EMA 201072.95Bullish
- EMA 501046.27Bullish
- DEMA 101099.09Bearish
- DEMA 201096.93Bearish
- DEMA 501076.53Bullish
- TEMA 101096.84Bearish
- TEMA 201102.91Bearish
- TEMA 501093.15Bullish
- MACD18.00Bullish
- ADX48.00Strong Trend
- IndicatorValueSignal
- RSI81.72Overbought
- CCI65.50Neutral
- ROC 90.73Bullish
- ROC 146.42Bullish
- ROC 257.25Bullish
- Stoch K91.72Overbought
- Stoch D91.33Overbought
- IndicatorValueSignal
- BB Upper1128.47Neutral
- BB Middle1068.37Neutral
- BB Lower1008.27Neutral
- ATR9.37Low Volatility
- IndicatorValueSignal
- MFI85.05Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 101077.14Bullish
- SMA 201051.22Bullish
- SMA 501017.94Bullish
- EMA 101077.68Bullish
- EMA 201058.51Bullish
- EMA 501031.41Bullish
- DEMA 101098.98Bearish
- DEMA 201087.72Bullish
- DEMA 501054.76Bullish
- TEMA 101102.65Bearish
- TEMA 201098.81Bearish
- TEMA 501075.89Bullish
- MACD22.84Bullish
- ADX40.59Strong Trend
- IndicatorValueSignal
- RSI79.22Overbought
- CCI99.65Neutral
- ROC 96.82Bullish
- ROC 147.39Bullish
- ROC 258.47Bullish
- Stoch K91.15Overbought
- Stoch D91.43Overbought
- IndicatorValueSignal
- BB Upper1114.33Neutral
- BB Middle1051.22Neutral
- BB Lower988.11Neutral
- ATR12.19Low Volatility
- IndicatorValueSignal
- MFI93.25Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 101051.55Bullish
- SMA 201031.00Bullish
- SMA 501017.39Bullish
- EMA 101059.20Bullish
- EMA 201037.86Bullish
- EMA 501019.71Bullish
- DEMA 101086.97Bullish
- DEMA 201064.42Bullish
- DEMA 501034.53Bullish
- TEMA 101097.04Bearish
- TEMA 201084.45Bullish
- TEMA 50N/AN/A
- MACD22.33Bullish
- ADX26.22Strong Trend
- IndicatorValueSignal
- RSI73.90Overbought
- CCI187.52Overbought
- ROC 96.65Bullish
- ROC 148.68Bullish
- ROC 2513.93Bullish
- Stoch K93.46Overbought
- Stoch D93.73Overbought
- IndicatorValueSignal
- BB Upper1093.16Overbought
- BB Middle1031.00Neutral
- BB Lower968.84Neutral
- ATR18.68High Volatility
- IndicatorValueSignal
- MFI72.31Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 101018.96Bullish
- SMA 201003.81Bullish
- SMA 501005.91Bullish
- SMA 1001011.45Bullish
- SMA 2001066.14Bullish
- EMA 101025.73Bullish
- EMA 201015.41Bullish
- EMA 501011.45Bullish
- EMA 1001023.19Bullish
- EMA 2001048.80Bullish
- DEMA 101045.01Bullish
- DEMA 201024.24Bullish
- DEMA 501008.21Bullish
- DEMA 100990.96Bullish
- DEMA 2001022.59Bullish
- TEMA 101061.01Bullish
- TEMA 201033.61Bullish
- TEMA 501020.35Bullish
- TEMA 100995.66Bullish
- TEMA 200967.29Bullish
- MACD8.83Bullish
- ADX16.02Weak Trend
- IndicatorValueSignal
- RSI69.67Neutral
- CCI156.91Overbought
- ROC 1412.99Bullish
- ROC 256.27Bullish
- Stoch K93.31Overbought
- Stoch D92.48Overbought
- IndicatorValueSignal
- BB Upper1081.02Overbought
- BB Middle1003.81Neutral
- BB Lower926.59Neutral
- ATR28.58High Volatility
- IndicatorValueSignal
- MFI73.69Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 201008.03Bullish
- SMA 501093.84Bearish
- EMA 201015.46Bearish
- EMA 501049.14Bearish
- DEMA 20981.71Bullish
- DEMA 501039.49Bearish
- TEMA 20984.90Bullish
- TEMA 50969.72Bullish
- MACD-22.85Bullish
- ADX25.71Strong Trend
- IndicatorValueSignal
- RSI47.37Neutral
- CCI-74.76Neutral
- ROC 14-2.84Bearish
- ROC 25-5.89Bearish
- Stoch K39.32Neutral
- Stoch D44.21Neutral
- IndicatorValueSignal
- BB Upper1090.58Neutral
- BB Middle1008.03Neutral
- BB Lower925.48Neutral
- ATR63.74High Volatility
- IndicatorValueSignal
- MFI39.38Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 61002.38Bearish
- SMA 121092.99Bearish
- SMA 241054.67Bearish
- EMA 61012.04Bearish
- EMA 121038.28Bearish
- EMA 24994.66Bearish
- DEMA 6969.72Bearish
- DEMA 121032.44Bearish
- DEMA 241136.11Bearish
- TEMA 6954.78Bullish
- TEMA 12967.14Bearish
- TEMA 241067.15Bearish
- MACD207.53Bearish
- ADX45.83Strong Trend
- IndicatorValueSignal
- RSI57.12Neutral
- CCI56.20Neutral
- ROC 2514.85Bullish
- ROC 50177.61Bullish
- Stoch K63.01Neutral
- Stoch D77.45Neutral
- IndicatorValueSignal
- BB Upper1261.69Neutral
- BB Middle1080.05Neutral
- BB Lower898.42Neutral
- ATR142.13High Volatility
- IndicatorValueSignal
- MFI46.82Neutral